Kurt J. Hilzinger, Director of Outlook Therapeutics OTLK, has filed 1 purchase and 0 sales on the open market. Over the past 12 months that comes to a net purchase of $176K. The latest trade was on 05/26.

KH

KH

Kurt J. Hilzinger

Director

Company

Outlook Therapeutics OTLK

First filing

23/01/04

Trades

31 trades

Buys / sales

1 / 0

12-month net buying

$176K

Last trade

05/26

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Outlook TherapeuticsOTLK	Open-market buy	05/26	05/27	400,000 sh	$0.44	$176,000	+1691.0%